Accord Sues Takeda Unit To Upend Crohn's Treatment Patents
Accord has sued a unit of pharma giant Takeda to revoke two of its patents covering treatment regimens for Crohn's disease, arguing that similar methods were explored in research elsewhere before...To view the full article, register now.
Already a subscriber? Click here to view full article